You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Also known as: Acquired Aplastic Anemia / Acquired Aplastic Anaemia
DrugDrug NameDrug Description
DB06412OxymetholoneOxymetholone is a synthetic anabolic steroid marketed under the brand name Anapolon by Hoffmann La Roche Limited. Its primary clinical applications include treatment of osteoporosis and anaemia, as well as stimulating muscle growth in malnourished or underdeveloped patients. Anabolic-androgenic steroids (AAS), such as oxymetholone, have been abused by bodybuilders and athletes. The uncontrolled misuse of oxymetholone can lead to a large variety of detrimental effects, the most often reported of which are cardiovascular events. In 2009, no producers of oxymetholone were identified worldwide (SRI 2009), but it was available from 14 suppliers, including 8 U.S. suppliers (ChemSources 2009).
DrugDrug NamePhaseStatusCount
DB00098Anti-thymocyte Globulin (Rabbit)2Completed1
DB00531Cyclophosphamide2Unknown Status1
DB00099Filgrastim2Unknown Status1
DB01073Fludarabine2Unknown Status1
DB00098Anti-thymocyte Globulin (Rabbit)3Recruiting1